Melatonin suppression of PC12 cell growth and death

Brain Research

Volumn 768, Issue 1-2, 1997, Pages 63-70

  Roth, Jerome A ^a   Rabin, Richard ^a   Agnello, Kimberly ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Cell death; Cell growth; Melatonin; PC12 cell; RZR nuclear receptor

Indexed keywords

6 CHLOROMELATONIN; CELL NUCLEUS RECEPTOR; CYCLIC AMP; FORSKOLIN; LACTATE DEHYDROGENASE; MELATONIN;

ANIMAL CELL; ARTICLE; CELL COUNT; CELL CULTURE; CELL DEATH; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CELL DEATH; CELL DIVISION; DEPRESSION, CHEMICAL; MELATONIN; PC12 CELLS; RATS;

EID: 0030764744     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00549-0     Document Type: Article

References (48)

1. Anderson K.M., Seed T., Plate M.D., Jajeh A., Meng J., Harris J.E. Selective inhibitors of 5-lipoxygenase reduce CML blast cell proliferation and induce limited differentiation and apoptosis. Leukemia Res. 19:1995;789-901.
2. Basma A.N., Morris E.J., Nicklas W.J., Geller H.M. L-Dopa cytotoxicity to PC12 cells in culture is via autooxidation. J. Neurochem. 64:1995;825-832.
3. Becker-André M., Wiesenberg I., Schaeren-Wiemers N., André E., Missbach M., Saurat J.-H., Carlberg C. Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily. J. Biol. Chem. 269:1994;28531-28534G.
4. 2+/calmodulin-dependent kinase II activity by melatonin. Biochim. Biophys. Acta. 1290:1996;191-196.
5. G. Brooker, J.F. Harper, W.L. Terasaki, R.D. Moylan, Radioimmunoassay of cyclic AMP and cyclic GMP, in: G. Brooker, P. Greengard, G.A. Robison (Eds.), Advances in Cyclic Nucleotide Research, vol. 10, Raven, New York, 1979, pp. 1-33.
6. Bubis M., Zisapel N. Modulation by melatonin of protein secretion from melanoma cells: is cAMP involved. Mol. Cell Endocrinol. 112:1995;169-175.
7. Cos S., Recio J., Sánchez-Barceló E.J. Modulation of the length of the cell cycle time of MCF-7 human breast cancer cells by melatonin. Life Sci. 58:1996;811-816.
8. Cos S., Fernández F., Sánchez-Barceló E.J. Melatonin inhibits DNA synthesis in MCF-7 human breast cancer cells in vitro. Life Sci. 58:1996;2447-2453.
9. Cos S., Sánchez-Barceló E.J. Melatonin inhibition of MCF-7 human breast-cancer cells growth: influence of cell proliferation rate. Cancer Lett. 93:1995;207-212.
10. Dubocovich M.L. Melatonin receptors: are there multiple subtypes? Trends Pharmacol. Sci. 16:1995;50-56.
11. Eison A.S., Mullins U.L. Melatonin binding sites are functionally coupled to phosphoinositide hydrolysis in syrian hamster RPMI 1846 melanoma cells. Life Sci. 53:1993;393-398.
12. Gilad E., Laudon M., Matzkin H., Pick E., Sofer M., Braf Z., Zisapel N. Functional melatonin receptors in human prostate epithelial cells. Endocrinology. 137:1996;1412-1417.
13. Godson C., Reppert S.M. The mel(1A) melatonin receptor is coupled to parallel signal transduction pathways. Endocrinology. 138:1996;397-404.
14. Greene L.A., Tischler A.S. PC12 pheochromocytoma cultures in neurobiological research. Adv. Cell Neurobiol. 3:1982;373-414.
15. Harland R.I., Balzer I., Poeggeler B., Fuhrberg B., Uria H., Behrmann G., Wolf R., Meyer T.J., Reiter R.J. On the primary functions of melatonin in evolution: Mediation of photoperiodic signals in a unicell, photooxidation, and scavenging of free radicals. J. Pineal Res. 18:1995;104-111.
16. Hill S.M., Blask D.E. Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res. 48:1988;6121-6126.
17. Huether G. Melatonin as an antiaging drug: between facts and fantasy. Gerontology. 42:1996;87-96.
18. Iuvone P.M., Gan J. Melatonin receptor-mediated inhibition of cyclic AMP accumulation in chick retinal cell cultures. J. Neurochem. 63:1994;118-124.
19. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurements with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
20. H.J. Lynch, A. Brzezinski, M.H. Deng, H. Lieberman, in: F. Fraschini, R.J. Reiter (Eds.), Advances in Pineal Research, vol. 2, Libbey, London, 1987, pp. 181- 189.
21. Melchiorri D., Reiter R.J., Sewerynek S., Hara M., Chen L., Nisticò G. Paraquat toxicity and oxidative damage, reduction by melatonin. Biochem. Pharmacol. 51:1996;1095-1099.
22. Pierpaoli W., Dall'ara A., Pedrinis E., Regelson W. The pineal control of aging. Ann. NY Acad. Sci. 64:1991;291-313.
23. Pierpaoli W., Regelson W. Pineal control of aging: effect of melatonin and pineal grafting on aging mice. Proc. Natl. Acad. Sci. USA. 91:1994;787-791.
24. Popova J.S., Dubocovich M.L. Melatonin receptor-mediated stimulation of phosphotide breakdown in chick brain slices. J. Neurochem. 64:1995;130-138.
25. Rabin R.A. Chronic ethanol exposure of PC12 cells alters adenylate cyclase activity and intracellular cyclic AMP content. J. Pharmacol. Exp. Ther. 252:1990;1021-1027.
26. Reiter R.J. Pineal melatonin: Cell biology of its synthesis and of its physiological consequences. Endocrine Rev. 12:1991;151-180.
27. Reiter R.J. Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J. 9:1995;526-533.
28. Reiter R.J., Melchiorri D., Sewerynek E., Poeggeler B., Barlow-Walden L., Chuang J., Ortiz G.G., Acuña-Castroviejo D. A review of the evidence supporting melatonin's role as an antioxidant. J. Pineal Res. 18:1995;1-11.
29. Reiter R.J., Oh C.-S., Fujimori O. Melatonin, its intracellular and genomic actions. Trends Endocrinol. Metab. 7:1996;22-27.
30. Reppert S.M., Weaver D.R., Ebisawa T. Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron. 13:1994;1177-1185.
31. Reppert S.M., Weaver D.R., Godson K. Melatonin receptors step into the light: cloning and classification of subtypes. Trends Pharmacol. Sci. 17:1996;100-102.
32. Roth J.A., Marcucci K., Lin W.H., Napoli J.L., Wagner J.A., Rabin R. Increase in β-1,4-galactosyltransferase activity during PC12 cell differentiation induced by forskolin and 2-chloroadenosine. J. Neurochem. 57:1991;708-713.
33. Sainz R.M., Mayo J.C., Uria H., Kotler M., Antolin I., Rodriguez C., Menendez-Palaez A. The pineal hormone melatonin prevents in vivo and in vitro apoptosis in thymocytes. J. Pineal Res. 19:1995;178-188.
34. Schräder M., Danielsson C., Iiesenberg I., Carlberg C. Identification of natural monomeric response elements of the nuclear receptor RZR/ROR. J. Biol. Chem. 271:1996;19732-19736.
35. Shafer T.J., Atchison W.D. Ion channel and receptor properties of pheochromocytoma (PC12) cells: A model for neurotoxicological studies. Neurotoxicology. 12:1991;473-492.
36. Slominski A., Pruski D. Melatonin inhibits proliferation and melanogenesis in rodent melanoma cells. Exp. Cell Res. 206:1993;189-194.
37. Soto A.M., Sonnenschein C. The role of estrogen on the proliferation of human breast tumor cells (MCF-7). J. Steroid Biochem. 23:1985;87-94.
38. Steinhilber D., Brungs M., Werz O., Wiesenberg I., Danielsson C., Kahlem J.-P., Nayeri S., Schräder M., Carlberg C. The nuclear receptor for melatonin represses 5-lipoxygenase gene expression in human B lymphocytes. J. Biol. Chem. 270:1995;7037-7040.
39. Sugden D. Melatonin: binding site characteristics and biochemical and cellular responses. Neurochem. Int. 24:1994;147-157.
40. Tan D.X., Chen L.D., Poeggeler B., Manchester R.J., Reiter R.J. Melatonin: A potent endogenous hydroxyl radical scavenger. Endocrine J. 1:1993;57-60.
41. Tan D.X., Reiter R.J., Chen L.D., Poeggeler B., Manchester L.C., Barlow-Walden L.R. Both physiological and pharmacological levels of melatonin reduce DNA adduct formation induced by the carcinogen safrole. Carcinogenesis. 15:1994;215-218.
42. van Grunsven L.A., Billon N., Savatier P., Thamas A., Urdiales J.L., Rudkin B.B. Effect of nerve growth factor on the expression of cell cycle regulatory proteins in PC12 cells: dissection of the neurotrophic response from the anti-mitogenic response. Oncogene. 12:1996;1347-1356.
43. 2+ not cAMP. Am. J. Physiol. 269:1995;E85-E90.
44. 2+ in neonatal rat pituitary cells. Endocrinology. 130:1992;701-707.
45. Vescovi A., Facheris L., Zaffaroni A., Malanca G., Parati E.A. Dopamine metabolism alterations in a manganese-treated pheochromocytoma cell line (PC12). Toxicology. 67:1991;129-142.
46. Weisenberg I., Missbach M., Kahlen J.-P., Schräder M., Carlberg C. Transcriptional activation of the nuclear receptor RZRα by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand. Nucl. Acids Res. 23:1995;327-333.
47. Yan G., Ziff E.B. NGF regulates PC12 cell cycle machinery through specific inhibition of the cdk kinases and induction of cyclin D1. J. Neurosci. 15:1995;6200-6212.
48. z proteins. FEBS Lett. 372:1995;99-102.